EGFR and non-small cell lung carcinoma: It was recently shown that the DNA methylation pattern in NSCLC cell lines and tissue samples correlates with phenotypic subsets associated with sensitivity to epidermal growth factor receptor (EGFR) inhibitors (Walter et al., 2012).